Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Objectives and Standards Quality of Care For tuberculosis (TB) programs, quality of care is measured by means of objectives. Such objectives are used as yardsticks to direct the program and measure its success. Objectives reflect outcomes or results and program desires. Programs require objectives to define expected outcomes and results for case management activities. In Alaska, TB program objectives are established from the following: State Statutes and Regulations Alaska Statutes and Regulations pertaining to the control of tuberculosis in Alaska are available in the Statutes and Regulations section of the manual 19.1. This information can also be found online in “Conditions Reportable to Public Health” at http://www.epi.alaska.gov/pubs/conditions/ConditionsReportable.pdf TB Program Agreements, Plans, and Protocols Centers for Disease Control and Prevention (CDC) Cooperative Agreement A copy of Alaska’s current “Tuberculosis in Alaska Annual Report” is available at the Tuberculosis Program website http://www.epi.hss.state.ak.us/id/tb.stm National TB Guidelines American Thoracic Society (ATS) Infectious Diseases Society of America (IDSA) CDC Division of Tuberculosis Elimination (DTBE) guidelines A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L Introduction 1.12 Revised November 2012
National and State Program Objectives Below are national and state TB program objectives. The CDC program objectives are current as of December 2006. 4 Under each national objective, there is a state objective established by the Alaska TB Program, based on Alaska’s epidemiology and recent program performance. Table 1: PROGRAM OBJECTIVES AND PERFORMANCE TARGETS Indicator 1 Percent completion of treatment National Tuberculosis Program Objectives and Performance Targets Increase timely completion of treatment National Objective: At least 93% of patients with newly diagnosed tuberculosis (TB), for whom therapy for 12 months or less is indicated, will complete treatment within 12 months by 2015. State Objective: At least 93% of persons with newly diagnosed TB, for whom therapy for one year or less is indicated, will complete therapy within 12 months by December 31, 2015. A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L Introduction 1.13 Revised November 2012
- Page 1 and 2: Alaska Tuberculosis Program Manual
- Page 3 and 4: Purpose............................
- Page 5 and 6: Monthly assessment of adherence ...
- Page 7 and 8: When to Expand a Contact Investigat
- Page 9 and 10: Introduction CONTENTS About the Ala
- Page 11 and 12: How to Use This Manual Portable Doc
- Page 13 and 14: Printing To access the print dialog
- Page 15 and 16: Abbreviations Refer to the list bel
- Page 17 and 18: QFT QuantiFERON ® -TB test QFT-G Q
- Page 19: Alaska Statutes and Regulations on
- Page 23 and 24: Indicator 3 Thorough contact invest
- Page 25 and 26: National Standards and Recommendati
- Page 27 and 28: Roles and Responsibilities Contact
- Page 29 and 30: Local Public Health Agencies Table
- Page 31 and 32: Resources and References Resources
- Page 33 and 34: Introduction Purpose Use this secti
- Page 35 and 36: Contact investigation: Collecting,
- Page 37 and 38: Reporting Tuberculosis Detecting an
- Page 39 and 40: Prompt reporting (prior to culture
- Page 41 and 42: Use the Infectious Disease Report F
- Page 43 and 44: Data Collection Forms The following
- Page 45 and 46: Genotyping Genotyping is a useful t
- Page 47 and 48: References 1 ATS, CDC, IDSA. Contro
- Page 49 and 50: Introduction Purpose Use this secti
- Page 51 and 52: child or a person acting on behalf
- Page 53 and 54: When to Conduct Targeted Testing Al
- Page 55 and 56: Alaska Program Standards for Health
- Page 57 and 58: B Notifications CONTENTS Introducti
- Page 59 and 60: Table 1: NUMBERS OF FOREIGN-BORN PE
- Page 61 and 62: chest radiograph and if sputum AFB
- Page 63 and 64: Follow-up of B1 and B2 Tuberculosis
- Page 65 and 66: Evaluation of B1, B2, and B Tubercu
- Page 67 and 68: Treatment Prescribe medications as
- Page 69 and 70: 12 Centers for Disease Control and
National and <strong>State</strong> <strong>Program</strong> Objectives<br />
Below are national and state TB program objectives. The CDC program objectives are<br />
current as <strong>of</strong> December 2006. 4 Under each national objective, there is a state objective<br />
established by the <strong>Alaska</strong> TB <strong>Program</strong>, based on <strong>Alaska</strong>’s epidemiology and recent<br />
program performance.<br />
Table 1: PROGRAM OBJECTIVES AND PERFORMANCE TARGETS<br />
Indicator<br />
1 Percent<br />
completion <strong>of</strong><br />
treatment<br />
National <strong>Tuberculosis</strong> <strong>Program</strong> Objectives<br />
and Performance Targets<br />
Increase timely completion <strong>of</strong> treatment<br />
National Objective: At least 93% <strong>of</strong> patients with newly diagnosed tuberculosis (TB),<br />
for whom therapy for 12 months or less is indicated, will complete treatment within<br />
12 months by 2015.<br />
<strong>State</strong> Objective: At least 93% <strong>of</strong> persons with newly diagnosed TB, for whom<br />
therapy for one year or less is indicated, will complete therapy within 12 months by<br />
December 31, 2015.<br />
A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L Introduction 1.13<br />
Revised November 2012
Change language